Anti-inflammatory drug used to treat gout does not reduce the risk of COVID-19 mortality

By | November 24, 2021
Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn’t lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, published in the open access journal RMD Open.